QA: Tenax Therapeutics INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000034956_2023_Tenax_Therapeutics_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0000034956, Tenax Therapeutics INC

  xvar xval
0 AssetsCurrent 3,208,465
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 7,189
3 remainder_Assets 189,055
4 LiabilitiesCurrent 1,847,772
5 LiabilitiesNoncurrent 64,196
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,621,019
9 ResearchAndDevelopmentExpense 5,156,664
10 remainder_Expenses 3,264
11 remainder_Revenues 7,121
12 remainder_NetIncome 2,957
13 remainder_ComprehensiveNetIncome 6,504,073
  yvar yval
0 Assets 3,404,709
1 Liabilities 1,911,968
2 Expenses 10,780,947
3 Revenues 7,121
4 StockholdersEquity 1,492,741
5 NetIncome -10,770,869
6 ComprehensiveNetIncome -7,518,832
7 BaseVar 11,305,888
8 EconomicCapitalRatiobeforeLimitedLiability -1.60
9 EconomicCapitalRatio 1.15

Edgar->Model Mapping

Feature Distribution

Change over Time